Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC ProjectCristiano Bortoluzzi, Paolo Simioni, Giuseppe Camporese et al.|Life|2022Cited by 5